Literature DB >> 19400979

Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Jagadeesh S Rao1, Stanley I Rapoport, Hyung-Wook Kim.   

Abstract

Overactivation of G-protein-mediated functions and altered G-protein regulation have been reported in bipolar disorder (BD) brain. Further, drugs effective in treating BD are reported to up-regulate expression of G-protein receptor kinase (GRK) 3 in rat frontal cortex. We therefore hypothesized that some G-protein subunits and GRK levels would be reduced in the brain of BD patients. We determined protein and mRNA levels of G-protein beta and gamma subunits, GRK2, and GRK3 in post-mortem frontal cortex from 10 BD patients and 10 age-matched controls by using immunoblots and real-time RT-PCR. There were statistically significant decreases in protein and mRNA levels of G-protein subunits beta and gamma and of GRK3 in BD brain but not a significant difference in the GRK2 level. Decreased expression of G-protein subunits and of GRK3 may alter neurotransmission, leading to disturbed cognition and behaviour in BD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400979      PMCID: PMC2738976          DOI: 10.1017/S146114570900025X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  65 in total

1.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.

Authors:  J A Pitcher; J Inglese; J B Higgins; J L Arriza; P J Casey; C Kim; J L Benovic; M M Kwatra; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

2.  The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain.

Authors:  J L Arriza; T M Dawson; R B Simerly; L J Martin; M G Caron; S H Snyder; R J Lefkowitz
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

3.  Mechanism of rhodopsin kinase activation.

Authors:  K Palczewski; J Buczyłko; M W Kaplan; A S Polans; J W Crabb
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

Review 4.  Interaction of antibipolar and antidepressant treatments with receptor-coupled G proteins.

Authors:  S Avissar; G Schreiber
Journal:  Pharmacopsychiatry       Date:  1992-01       Impact factor: 5.788

Review 5.  Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders.

Authors:  S Avissar; G Schreiber
Journal:  Biol Psychiatry       Date:  1992-03-01       Impact factor: 13.382

Review 6.  Muscarinic acetylcholine receptors: signal transduction through multiple effectors.

Authors:  C C Felder
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

7.  Elevated PLA2 activity in schizophrenics and other psychiatric patients.

Authors:  M Noponen; M Sanfilipo; K Samanich; H Ryer; G Ko; B Angrist; A Wolkin; E Duncan; J Rotrosen
Journal:  Biol Psychiatry       Date:  1993-11-01       Impact factor: 13.382

8.  The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase.

Authors:  W J Koch; J Inglese; W C Stone; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

9.  Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder.

Authors:  L T Young; P P Li; S J Kish; K P Siu; A Kamble; O Hornykiewicz; J J Warsh
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

10.  D1 dopamine receptor binding in mood disorders measured by positron emission tomography.

Authors:  T Suhara; K Nakayama; O Inoue; H Fukuda; M Shimizu; A Mori; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  12 in total

1.  Genes and gene networks implicated in aggression related behaviour.

Authors:  Karim Malki; Oliver Pain; Ebba Du Rietz; Maria Grazia Tosto; Jose Paya-Cano; Kenneth N Sandnabba; Sietse de Boer; Leonard C Schalkwyk; Frans Sluyter
Journal:  Neurogenetics       Date:  2014-08-22       Impact factor: 2.660

2.  Overexpression of diacylglycerol kinase η enhances Gαq-coupled G protein-coupled receptor signaling.

Authors:  Joseph E Rittiner; Victoria E Brings; Mark J Zylka
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

3.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.

Authors:  B Mark Woerner; Jingqin Luo; Kristin R Brown; Erin Jackson; Sonika M Dahiya; Paul Mischel; Jeffrey L Benovic; David Piwnica-Worms; Joshua B Rubin
Journal:  Mol Cancer Res       Date:  2011-11-15       Impact factor: 5.852

Review 5.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Authors:  Mireille Basselin; Epolia Ramadan; Stanley I Rapoport
Journal:  Brain Res Bull       Date:  2011-12-09       Impact factor: 4.077

6.  Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.

Authors:  Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

7.  Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.

Authors:  Michael J McCarthy; Thomas B Barrett; Stephanie Nissen; John R Kelsoe; Eric E Turner
Journal:  J Psychiatr Res       Date:  2009-09-18       Impact factor: 4.791

8.  Brain lipid concentrations in bipolar disorder.

Authors:  Miki Igarashi; Kaizong Ma; Fei Gao; Hyung-Wook Kim; Deanna Greenstein; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2009-09-19       Impact factor: 4.791

9.  Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.

Authors:  J S Rao; G J Harry; S I Rapoport; H W Kim
Journal:  Mol Psychiatry       Date:  2009-06-02       Impact factor: 15.992

Review 10.  Bipolar disorder and mechanisms of action of mood stabilizers.

Authors:  Stanley I Rapoport; Mireille Basselin; Hyung-Wook Kim; Jagadeesh S Rao
Journal:  Brain Res Rev       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.